Medicated feed: Initial Appraisal of a European Commission Impact Assessment

13-04-2015

This note seeks to provide an initial analysis of the strengths and weaknesses of the European Commission's Impact Assessment (IA) accompanying the proposal for Regulation on the manufacture, placing on the market and use of medicated feed and repealing Council Directive 90/167/EEC (COM (2014) 556). This note, prepared by the Ex-Ante Impact Assessment Unit for the Committee on Agriculture and Rural Development (AGRI) of the European Parliament, analyses whether the principal criteria laid down in the Commission’s own Impact Assessment Guidelines, as well as additional factors identified by the Parliament in its Impact Assessment Handbook, appear to be met by the IA.

This note seeks to provide an initial analysis of the strengths and weaknesses of the European Commission's Impact Assessment (IA) accompanying the proposal for Regulation on the manufacture, placing on the market and use of medicated feed and repealing Council Directive 90/167/EEC (COM (2014) 556). This note, prepared by the Ex-Ante Impact Assessment Unit for the Committee on Agriculture and Rural Development (AGRI) of the European Parliament, analyses whether the principal criteria laid down in the Commission’s own Impact Assessment Guidelines, as well as additional factors identified by the Parliament in its Impact Assessment Handbook, appear to be met by the IA.